title: Subtyping clinical specimens of influenza A virus by use of a simple method to amplify RNA targets.
abstract: This work presents the clinical application of a robust and unique approach for RNA amplification, called a simple method for amplifying RNA targets (SMART), for the detection and identification of subtypes of H1N1 pandemic, H1N1 seasonal, and H3N2 seasonal influenza virus. While all the existing amplification techniques rely on the diffusion of two molecules to complex RNA structures, the SMART achieves fast and efficient amplification via single-molecule diffusion. The SMART utilizes amplifiable single-stranded DNA (ssDNA) probes, which serve as reporter molecules for capturing specific viral RNA (vRNA) sequences and are subsequently separated on a microfluidic chip under zero-flow conditions. The probe amplification and detection are performed using an isothermal (41°C) amplification scheme via a modified version of nucleic acid sequence-based amplification (NASBA). In our study, 116 consecutive, deidentified, clinical nasopharyngeal swab samples were analyzed independently in a blinded fashion using the SMART, reverse transcription-PCR (RT-PCR), antigen (Ag) testing, and viral culture. The SMART was shown to have a limit of detection (LOD) of approximately 10(5) vRNA copies/ml, corresponding with a time-to-positivity (TTP) value of 70 min for real-time detection. The SMART correctly detected influenza virus in 98.3% of the samples with a subtyping accuracy of 95.7%. This work demonstrates that the SMART represents a highly accurate diagnostic platform for the detection and subtyping of influenza virus in clinical specimens and offers significant advantages over the current commercially available diagnostic tools.
authors.affiliation: Center for Biomedical Engineering, School of Engineering and Division of Biology and Medicine, Brown University, Providence, Rhode Island, USA.
authors.forename: Jingjing
authors.initials: J
authors.lastname: Wang
authors.forename: Warren
authors.initials: W
authors.lastname: Tai
authors.forename: Stephanie L
authors.initials: SL
authors.lastname: Angione
authors.forename: Amrita R
authors.initials: AR
authors.lastname: John
authors.forename: Steven M
authors.initials: SM
authors.lastname: Opal
authors.forename: Andrew W
authors.initials: AW
authors.lastname: Artenstein
authors.forename: Anubhav
authors.initials: A
authors.lastname: Tripathi
mesh_terms: D000328:Adult; D004277:DNA, Single-Stranded; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D053122:Influenza A Virus, H3N2 Subtype / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D007251:Influenza, Human / Q000175:diagnosis / Q000821:virology*; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D015345:Oligonucleotide Probes; D012367:RNA, Viral / Q000235:genetics* / Q000302:isolation & purification; D014773:Virology / Q000379:methods*
chemical_list: D004277:DNA, Single-Stranded; D015345:Oligonucleotide Probes; D012367:RNA, Viral
references.citation: MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
references.pmid: 18685555
references.citation: J Clin Microbiol. 2003 May;41(5):2180-3
references.pmid: 12734274
references.citation: J Virol Methods. 1995 Mar;52(1-2):121-32
references.pmid: 7769025
references.citation: Biochem Biophys Res Commun. 2003 Jan 10;300(2):507-15
references.pmid: 12504113
references.citation: Lab Chip. 2013 Jan 7;13(1):51-67
references.pmid: 23044793
references.citation: Lancet Infect Dis. 2005 Nov;5(11):666-7
references.pmid: 16253881
references.citation: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1874-8
references.pmid: 2308948
references.citation: J Mol Diagn. 2012 Jul;14(4):328-35
references.pmid: 22691910
references.citation: J Clin Microbiol. 1997 Jun;35(6):1579-81
references.pmid: 9163486
references.citation: J Med Virol. 2010 Jan;82(1):1-7
references.pmid: 19950247
references.citation: J Infect Dis. 2006 Nov 1;194 Suppl 2:S98-110
references.pmid: 17163396
references.citation: Am J Public Health. 2009 Oct;99 Suppl 2:S225-30
references.pmid: 19797736
references.citation: Nucleic Acids Res. 2003 Jan 15;31(2):750-8
references.pmid: 12527785
references.citation: Biochem Biophys Res Commun. 2004 Jan 9;313(2):336-42
references.pmid: 14684165
references.citation: Mol Biotechnol. 2002 Feb;20(2):163-79
references.pmid: 11876473
references.citation: Pediatrics. 2003 Aug;112(2):363-7
references.pmid: 12897288
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5935-40
references.pmid: 16585506
references.citation: N Engl J Med. 2010 May 6;362(18):1708-19
references.pmid: 20445182
references.citation: Nat Biotechnol. 2006 Aug;24(8):891-3
references.pmid: 16900120
references.citation: N Engl J Med. 2005 Sep 29;353(13):1374-85
references.pmid: 16192482
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Jun 3;60(21):705-12
references.pmid: 21637185
references.citation: J Virol Methods. 1996 Jul;60(2):161-70
references.pmid: 8844622
references.citation: Emerg Infect Dis. 2006 Jan;12(1):73-7
references.pmid: 16494721
references.citation: Nat Biotechnol. 2004 Mar;22(3):267
references.pmid: 14990943